Silver Oak Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Silver Oak Securities’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,579	Closed	-$250K	–	494
2023 Q4	$250K	Sell	1,579 -427,569	-100%	-$61.4M	0.03%	415
2023 Q3	$31.7M	Buy	+429,148	New	+$65.4M	6.89%	2
2023 Q2	–	Sell	-1,943	Closed	-$301K	–	444
2023 Q1	$301K	Sell	1,943 -159	-8%	-$25K	0.05%	281
2022 Q4	$324K	Sell	2,102 -427,046	-100%	-$63M	0.06%	218
2022 Q3	$31.7M	Buy	+429,148	New	+$60.2M	6.89%	2

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Silver Oak Securities's FBT Position: Q1 2024 in Review

Silver Oak Securities sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2024, closing a stake of 1,579 shares — an estimated $250K sold.

Silver Oak Securities first reported a position in FBT in Q3 2022 and held it in 5 quarters. The position peaked at $31.7M in Q3 2023. 243 funds tracked by Wall St. Rank hold FBT as of Q1 2024.

Silver Oak Securities reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2024 after selling out during the quarter.
Silver Oak Securities sold 1,579 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2024, an estimated $250K.
Silver Oak Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2022 and held it in 5 quarters.
Silver Oak Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $31.7M in Q3 2023.
243 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2024.

Based on Silver Oak Securities's 13F filing for Q1 2024, filed 10 May 2024.